Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis. - Wikidata - awgldk - TriplyDB

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis.

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis.

http://www.wikidata.org/entity/Q37418199

about

Osteoprotegerin rich tumor microenvironment: implications in breast cancer From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease Osteoprotegerin expressed by osteoclasts: an autoregulator of osteoclastogenesis.Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury.Assessment of selected cytokines, proteins, and growth factors in the peritoneal fluid of patients with ovarian cancer and benign gynecological conditions.Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women.Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers Osteoprotegerin secreted by inflammatory and invasive breast cancer cells induces aneuploidy, cell proliferation and angiogenesis.Androgen deprivation therapy sensitizes triple negative breast cancer cells to immune-mediated lysis through androgen receptor independent modulation of osteoprotegerin.NADPH oxidases in bone homeostasis and osteoporosis.Cytosolic calreticulin inhibits microwave radiation-induced microvascular endothelial cell injury through the integrin-focal adhesion kinase pathway.Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy.

P2860

Q26748804-F20BC3B4-6310-485A-B2CF-17BA253583EB Q28076305-AB46BE34-FD84-4D45-8F7F-055F08478EDE Q34950497-97F02DB9-5D84-4F17-85AC-661DC267CE26 Q35132945-C403A417-1636-49B5-AF1E-696265E126FB Q35142408-AA8C1649-7A38-4C7F-AF9B-2175D533E5B2 Q35424630-90242FD0-784E-4746-BED5-FEA2F0310059 Q35677625-42E11973-B846-42CF-9F94-081FD9C2F553 Q35853271-18A6963A-7667-43BB-8FF7-C1247371CBE0 Q37269053-2AC50AD5-A8D3-4368-BE19-782131865BF2 Q38244251-1768184E-3391-4EEC-B43A-E22B34C1E7B5 Q54344549-27A10A86-1749-4731-A7DF-9C2000E5CF73 Q55406267-52AD4346-CB7C-478A-B96E-BECC41E8D9AF

P2860

Osteoprotegerin (OPG) activates integrin, focal adhesion kinase (FAK), and Akt signaling in ovarian cancer cells to attenuate TRAIL-induced apoptosis.

http://www.wikidata.org/entity/Q37418199

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Osteoprotegerin (OPG) activate ...... nuate TRAIL-induced apoptosis.

@en

Osteoprotegerin (OPG) activate ...... nuate TRAIL-induced apoptosis.

@nl

type

label

Osteoprotegerin (OPG) activate ...... nuate TRAIL-induced apoptosis.

@en

Osteoprotegerin (OPG) activate ...... nuate TRAIL-induced apoptosis.

@nl

prefLabel

Osteoprotegerin (OPG) activate ...... nuate TRAIL-induced apoptosis.

@en

Osteoprotegerin (OPG) activate ...... nuate TRAIL-induced apoptosis.

@nl

P1433

Q37418199-ECAC81AD-FA93-4D8D-97F4-BEF0ADB80321

P1476

Q37418199-98CE9A6D-7E27-4F0A-8A0E-AD9653D9DD30

P2093

Q37418199-37042B75-A07E-4F84-BDCF-38AFDE2D1578

Q37418199-54E65DE7-573A-4B9A-B2E7-B046383A28B2

Q37418199-5C5497CD-F580-4015-9015-35196F5A2C73

Q37418199-F08942B9-D2B0-4B0A-A5E1-C083306CB62E

Q37418199-FBFF9F87-72E4-4046-8E1E-976EA2C699F9

Q37418199-FCD0B287-4E49-4B13-B810-6DE37D28863D

P2860

Q37418199-0C28FE08-7904-411A-BEB0-B68D4267BD97

Q37418199-120191FB-5196-4A27-BCE2-5449AB83F760

Q37418199-1D80D837-C684-4557-9FC8-EA49E188FAAE

Q37418199-29CC95F1-E6E4-40B8-BD1E-A554757E33F3

Q37418199-2C3A5E96-9608-4E37-B885-219C725C042B

Q37418199-35CEE320-92C1-4FA8-8BE3-D87E42246456

Q37418199-3DEF02F5-F519-4DF0-8469-10FF88BAD523

Q37418199-413215F6-E462-49CC-A0E3-305607035678

Q37418199-479941B3-B792-4503-87D9-E8B0FEC8E953

Q37418199-540D19E0-F057-42A1-AF92-49A3B43CCC39

P2888

Q37418199-A9DF5762-AD24-4685-9984-2161D7FBDE1C

P304

Q37418199-EE528140-4BA5-4414-BB10-1632A29C4E02

P31

Q37418199-43A01479-580F-4C32-8137-DEB62E2CCB87

P356

Q37418199-603C35F5-64AF-489A-9854-52238464CC7F

P433

Q37418199-8881ECF5-C1F2-48A2-B606-1F2C2A675040

P478

Q37418199-597BB026-8543-47BE-82B8-5A6E82FB35D8

P577

Q37418199-CC479286-2D57-4408-83D5-97155B0881B3

P5875

Q37418199-42EB14D6-2CC4-4674-B473-FE3F073EF68F

P6179

Q37418199-32CA5DAA-594E-42D8-B57F-D133724A2B30

P698

Q37418199-8C9B990F-E7E8-4EAE-B82B-A77592D6172C

P921

Q37418199-14999FD5-F28B-4328-8585-EC7F3D982E77

Q37418199-8476BB86-8639-41E2-B7A8-A4E021DDE636

P932

Q37418199-B195110C-01A5-4F19-915D-BC48662A7A20

P356

P1433

Journal of Ovarian Research

P1476

Osteoprotegerin (OPG) activate ...... nuate TRAIL-induced apoptosis.

@en

P2093

Alain Piché

http://www.w3.org/2001/XMLSchema#string

Claude Laplante

http://www.w3.org/2001/XMLSchema#string

Claudine Rancourt

http://www.w3.org/2001/XMLSchema#string

Denis Lane

http://www.w3.org/2001/XMLSchema#string

Isabelle Matte

http://www.w3.org/2001/XMLSchema#string

Perrine Garde-Granger

http://www.w3.org/2001/XMLSchema#string

P2860

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Temperature-sensitive differential affinity of TRAIL for its receptors. DR5 is the highest affinity receptor

Get a ligand, get a life: integrins, signaling and cell survival

The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells.

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro.

Osteoprotegerin is a receptor for the cytotoxic ligand TRAIL.

Targeted ovarian cancer treatment: the TRAILs of resistance.

Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis

Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis

The importance of the PI3K/AKT/MTOR pathway in the progression of ovarian cancer.

P2888

P304

82

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1757-2215-6-82

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258851615

http://www.w3.org/2001/XMLSchema#string

P6179

1000832349

http://www.w3.org/2001/XMLSchema#string

P698

24267510

http://www.w3.org/2001/XMLSchema#string

P921

apoptotic process

P932

3874685

http://www.w3.org/2001/XMLSchema#string